Temasek, Creador, Kedaara look to buy into pharma co Integrace; True North may sell 30% stake

Singapore's Temasek Holdings, Kuala Lumpur's Creador and Kedaara Capital are in separate talks to acquire a significant minority stake in Integrace, a Mumbai-based pharmaceutical formulations manufacturer. True North, the private equity fund which owns Integrace, will sell about 25-30% stake to the potential investor. The deal is likely to value Integrace at INR 1,300-1,400 crore. Investment bank Rothschild is advising True North on the stake sale.